Caputo GM, Cavanagh PR, Ulbrecht JS, Gibbons GW, Karchmer AW. Assessment <strong>and</strong> management <strong>of</strong>foot disease <strong>in</strong> patients with diabetes. N Engl J Med 1994;331:854-60.Carr<strong>in</strong>gton AL, Abbott CA, Griffiths J, Jackson N, Johnson SR, Kulkarni J, Van Ross ER, Boulton AJ.Peripheral vascular <strong>and</strong> nerve function associated with lower limb amputation <strong>in</strong> people with <strong>and</strong>without diaebtes. Cl<strong>in</strong> Sci 2001b;101:261-6.Cavanagh PR, Simoneau GG, Ulbrecht JS. Ulceration, unstead<strong>in</strong>ess, <strong>and</strong> uncerta<strong>in</strong>ty: thebiomechanical consequences <strong>of</strong> diabetes mellitus. J Biomech 1993;26(Suppl 1):23-40.Cerveny JD, Leder RD, Weart CW. Issues surround<strong>in</strong>g tight glycemic control <strong>in</strong> people with <strong>Type</strong> 2diabetes mellitus. Ann Pharmacother 1998;32:896-905.Chantelau E, Kushner T, Spraul M. How effective is cushioned therapeutic footwear <strong>in</strong> protect<strong>in</strong>gdiabetic feet? A cl<strong>in</strong>ical study. Diabet Med 1990;7:355-9.Chew JT, Tan SB, Sivathasan C, Pavanni R, Tan SK. Vascular assessment <strong>in</strong> the neuropathic diabeticfoot. Cl<strong>in</strong> Orthop 1995;320:95-100.Clark CM Jr, Snyder JW, Meek RL, Stutz LM, Park<strong>in</strong> CG. A systematic approach to risk stratification<strong>and</strong> <strong>in</strong>tervention with<strong>in</strong> a managed care environment improves diabetes outcomes <strong>and</strong> patientsatisfaction. <strong>Diabetes</strong> Care 2001;24:1079-86.Collier J, Brodbeck C. Assess<strong>in</strong>g the diabetic foot: plantar callus <strong>and</strong> pressure sensation. <strong>Diabetes</strong> Educ1993;19:503-8.Colman PG, Beischer AD. Lower-limb amputation <strong>and</strong> diabetes: the key is prevention. MJA2000;173:341-2.Copp<strong>in</strong>i DV, Weng C, Jones MC, Sonksen PH. Cumulative <strong>in</strong>cidence <strong>of</strong> foot complications <strong>in</strong> paatientsfirst attend<strong>in</strong>g a UK diabetes cl<strong>in</strong>ic <strong>in</strong> 1982-85: a 12-year prospective study. The <strong>Foot</strong>: InternationalJournal <strong>of</strong> Cl<strong>in</strong>ical <strong>Foot</strong> Science 1997;7:215-9.Dalla Paola L, Faglia E, Cam<strong>in</strong>iti M, Clerici G, N<strong>in</strong>kovic S, Deanesi V. Ulcer recurrence follow<strong>in</strong>gfirst ray amputation <strong>in</strong> diabetic patients: a cohort prospective study. <strong>Diabetes</strong> Care 2003;26:1874-8.Davidson JK, Alogna M, Goldsmith M, Borden J. Assessment <strong>of</strong> program effectiveness at GradyMemorial Hospital-Atlanta. In: Ste<strong>in</strong>er S, Lawrence PA. Educat<strong>in</strong>g Diabetic Patients. Spr<strong>in</strong>ger-Verlag,New York. 1981;329-48.Davies S, Gibby O, Phillips C, Price P, Tyrrell W. The health status <strong>of</strong> diabetic patients receiv<strong>in</strong>gorthotic therapy. Qual Life Res 2000;9:233-40.De P, Scarpello JHB. What is the evidence for effective treatment <strong>of</strong> diabetic foot ulceration? Pract<strong>Diabetes</strong> Int 1999;16:179-84.de Sonnaville JJ, Colly LP, Wijkel D, He<strong>in</strong>e RJ. The prevalence <strong>and</strong> determ<strong>in</strong>ants <strong>of</strong> foot ulceration <strong>in</strong>type II diabetic patients <strong>in</strong> a primary health care sett<strong>in</strong>g. <strong>Diabetes</strong> Res Cl<strong>in</strong> Pract 1997;35:149-56.de Wytt CN, Jackson RV, Hock<strong>in</strong>gs GI, Joyner JM, Strakosch CR. Polyneuropathy <strong>in</strong> Australianoutpatients with <strong>Type</strong> 2 diabetes mellitus. J <strong>Diabetes</strong> Complications 1999;13:74-8.Del Aguila MA, Reiber GE, Koepsell TD. How does provider <strong>and</strong> patient awareness <strong>of</strong> high risk statusfor lower-extremity amputation <strong>in</strong>fluence foot-care practice? <strong>Diabetes</strong> Care 1994;17:1050-4.Delbridge L, Appleberg M, Reeve TS. Factors associated with the development <strong>of</strong> foot lesions <strong>in</strong> thediabetic. Surgery 1983;93:78-82.Dimitrakoudis D, Bril V. Comparison <strong>of</strong> sensory test<strong>in</strong>g on different toe surfaces: implications forneuropathy screen<strong>in</strong>g. Neurology 2002;59:611-3.116
Donaghue VM, Sarnow MR, Giurni JM, Chrzan JS, Habershaw GM, Veves A. Longitud<strong>in</strong>al <strong>in</strong>-shoefoot pressure relief achieved by specially designed footwear <strong>in</strong> high risk diabetic patients. <strong>Diabetes</strong> ResCl<strong>in</strong> Pract 1996;31:109-14.Donohoe ME, Fletton JA, Hook A, Powell R, Rob<strong>in</strong>son I, Stead JW, Sweeney K, Taylor R, Tooke JE.Improv<strong>in</strong>g foot care for people with diabetes mellitus - a r<strong>and</strong>omised controlled trial <strong>of</strong> an <strong>in</strong>tergratedcare approach. Diabet Med 2000;17:581-7.Edmonds M, Boulton A, Buckenham T, Every N, Foster A, Freeman D, Gadsby R, Gibby O, KnowlesA, Pooke M, Tovey F, Unw<strong>in</strong> N, Wolfe J. Report <strong>of</strong> the diabetic foot <strong>and</strong> amputation group. DiabetMed 1996;13(Suppl 1):S27-42.Edmonds ME, Van Acker K, Foster AV. Education <strong>and</strong> the diabetic foot. Diabet Med1996;13:Suppl1:S61-4.el-Shazly M, Abdel-Fattah M, Scorpiglione N, Benedetti MM, Capani F, Car<strong>in</strong>ci F, Carta Q, CavaliereD, De Feo EM, Taboga C, Tognoni G, Nicolucci A. Risk factors for lower limb complications <strong>in</strong>diabetic patients. J <strong>Diabetes</strong> Complications 1998;12:10-7.Espensen EH, Nixon BP, Armstrong DG. Chemical matrixectomy for <strong>in</strong>grown toenails. Is there anevidence basis to guide therapy? J Am Podiatr Med Assoc 2002;92:287-95.Faglia E, Favales F, Aldeghi A, Calia P, Quarantiello A, Barbano P, Putt<strong>in</strong>i M, Palmieri B, BrambillaG, Rampoldi A, Mazzola E, Valenti L, Fattori G, Rega V, Cristalli A, Oriani G, Micheal M, MorabitoA. Change <strong>in</strong> major amputation rate <strong>in</strong> a center dedicated to diabetic foot care dur<strong>in</strong>g the 1980s:prognostic determ<strong>in</strong>ants for major amputation. J <strong>Diabetes</strong> Complications 1998;12:96-102.Faglia E, Favales F, Morabito A. New ulcreation, new major amputation, <strong>and</strong> survival rates <strong>in</strong> diabeticsubjects hospitalised for foot ulceration from 1990 to 1993: a 6.5-year follow-up. <strong>Diabetes</strong> Care2001:24:78-83.Fedele D, Comi G, Coscelli C, Cuc<strong>in</strong>otta D, Feldman EL, Ghirl<strong>and</strong>a G, Greene DA, Negr<strong>in</strong> P,Santeusanio F, the Italian Diabetic Neuropathy Committee. A multicenter study on the prevalence <strong>of</strong>diabetic neuropathy <strong>in</strong> Italy. <strong>Diabetes</strong> Care 1997;20:836-43.Ferguson MW, Herrick SE, Spencer MJ, Shaw JE, Boulton AJ, Sloan P. The histology <strong>of</strong> diabetic footulcers. Diabet Med 1996;13:Suppl 1: S30-3.Flores Rivera AR. Risk factors for amputation <strong>in</strong> diabetic patients: a case-control study. Arch Med Res1998;29:179-84.Flynn MD, Tooke JE. Aetiology <strong>of</strong> diabetic foot ulceration: a role for the microcirculation? DiabetMed 1992;9:320-9.Foster AV, Snowden S, Grenfell A, Watk<strong>in</strong>s PJ, Edmonds ME. Reduction <strong>of</strong> gangrene <strong>and</strong> amputations<strong>in</strong> diabetic renal transplant patients: the role <strong>of</strong> a special foot cl<strong>in</strong>ic. Diabet Med 1995;12:632-5.Fowkes FG, Housley E, Cawood EH, Mac<strong>in</strong>tyre CC, Ruckley CV, Prescott RJ. Ed<strong>in</strong>burgh ArteryStudy: prevalence <strong>of</strong> asymptomatic <strong>and</strong> symptomatic peripheral arterial disease <strong>in</strong> the generalpopulation. Int J Epidemiol 1991;20:384-92.Foster A. Cut <strong>and</strong> come aga<strong>in</strong>: a multidiscipl<strong>in</strong>ary approach to foot problems can avoid amputations.Pract <strong>Diabetes</strong> Int 1997;14:3.Fotieo GG, Reiber GE, Carter JS, Smith DG. Diabetic amputations <strong>in</strong> the VA: are there opportunitiesfor <strong>in</strong>terventions? J Rehabil Res Dev 1999;36:55-9Frykberg RG. The team approach <strong>in</strong> diabetic management. Adv Wound Care 1998;11:71-7.117
- Page 1:
National Evidence Based Guidelinesf
- Page 4:
Research OfficersMs Linda SmithPodi
- Page 7 and 8:
2.2 Issues for Foot Problems in Typ
- Page 9:
• Aim to achieve the best possibl
- Page 12 and 13:
Background - Peripheral Neuropathy
- Page 14 and 15:
proportion of subjects with a durat
- Page 16 and 17:
and an OR 1.1-7.8. This study also
- Page 18 and 19:
Summary - Peripheral Neuropathy as
- Page 20 and 21:
Section 2: Diabetes Foot ProblemsIs
- Page 22 and 23:
predicting risk of amputation, 2.9
- Page 24 and 25:
Summary - Peripheral Vascular Disea
- Page 26 and 27:
Section 3: Diabetes Foot ProblemsIs
- Page 28 and 29:
Evidence - Foot Deformity and Previ
- Page 30 and 31:
people with both LJM and neuropathy
- Page 32 and 33:
Summary - Foot Deformity and Previo
- Page 34 and 35:
Section 4: Diabetes Foot ProblemsIs
- Page 36 and 37:
Also in the Seattle study, 67 peopl
- Page 38 and 39:
Summary - Ulcer as a Risk Factor fo
- Page 40 and 41:
Section 5: Diabetes Foot ProblemsIs
- Page 42 and 43:
The other frequently reported metho
- Page 44 and 45:
side; and 82% having the same resul
- Page 46 and 47:
Evidence Table: Section 5Detection
- Page 48 and 49:
Background - Clinical Detection of
- Page 50 and 51:
pulse was bilaterally absent in 1.8
- Page 52 and 53:
Evidence Table: Section 6AuthorClin
- Page 54 and 55:
Background - Frequency of Foot Exam
- Page 56 and 57:
Summary - Frequency of Foot Examina
- Page 58 and 59:
Section 8: Diabetes Foot ProblemsIs
- Page 60 and 61:
Behaviour assessment scores, measur
- Page 62 and 63:
Mazzuca et al (1986) studies 532 pe
- Page 64 and 65:
with before the programme, after 1-
- Page 66 and 67: Evidence Table: Section 8AuthorEffe
- Page 68 and 69: Background - Glycaemic Control and
- Page 70 and 71: In a previous Japanese randomised s
- Page 72 and 73: Evidence Table: Section 9AuthorGlyc
- Page 74 and 75: Background - Footwear to Reduce Ulc
- Page 76 and 77: period. In addition people without
- Page 78 and 79: Comparisons of in-shoe foot pressur
- Page 80 and 81: The rate of plantar callus formatio
- Page 82 and 83: Evidence Table: Section 10AuthorFoo
- Page 84 and 85: Background - Foot Clinics and Multi
- Page 86 and 87: A prospective non randomised contro
- Page 88 and 89: Summary - Foot Clinics and Multi-di
- Page 90 and 91: Section 12: Diabetes Foot ProblemsI
- Page 92 and 93: and/or osteomyelitis; III - fore-fo
- Page 94 and 95: Summary - Economic consequences•
- Page 96 and 97: Section 13: Diabetes Foot ProblemsI
- Page 98 and 99: Some ethnic groups are associated w
- Page 100 and 101: Evidence Table: Section 13AuthorSoc
- Page 102 and 103: Calle-Pascual AL, Duran A, Diaz A,
- Page 104 and 105: Jannink MJ, van Dijk H, de Vries J,
- Page 106 and 107: Moss SE, Klein R, Klein BE. The 14-
- Page 108 and 109: Soulier SM, Godsey C, Asay ED, Perr
- Page 110 and 111: Diabetes Foot Problems: General Ref
- Page 112 and 113: McNeely MJ, Boyko EJ, Ahroni JH, St
- Page 114 and 115: Diabetes Foot Problems: Other Refer
- Page 118 and 119: Garbalosa JC, Cavanagh PR, Wu G, Ul
- Page 120 and 121: Lavery LA, Armstrong DG, Wunderlich
- Page 122 and 123: Payne C. Regional variations of dia
- Page 124 and 125: Tovi J, Svanborg E, Nilsson BY, Eng
- Page 126 and 127: Criteria used to determine the suit
- Page 128 and 129: QUESTIONS KEY WORDS NO.ARTICLESIDEN
- Page 130 and 131: QUESTIONS KEY WORDS NO.ARTICLESIDEN
- Page 132 and 133: QUESTIONS KEY WORDS NO.ARTICLESIDEN
- Page 134 and 135: QUESTIONS KEY WORDS NO.ARTICLESIDEN
- Page 136 and 137: QUESTIONS KEY WORDS NO.ARTICLESIDEN
- Page 138 and 139: QUESTIONS KEY WORDS NO.ARTICLESIDEN